PURA CEO Interview Discussing New Hemp Strategy To Expand Reach Into $26 Billion Market Scheduled For Release On Monday, November 16, 2020

By: OTC

Dallas, Texas, November 13, 2020 – OTC PR WIRE — Puration, Inc. (OTC US: PURA) today announced an interview of CEO Brian Shibley conducted by CEO Roadshow in association with OTC PR Wire (www.otcprwire.com) – the #1 solution for press, financial disclosure and multimedia solutions for companies trading in the OTC Market, will be released on Monday, November 16, 2020.  The interview will focus on PURA’s recent acquisition of a 72-acre property in Farmersville, Texas as the foundation of an innovative, hemp processing plant. PURA is building partnerships to participate in the project to include a pharmaceutical and neurocritical extraction partnership with PAO Group, Inc. (OTC US: PAOG) and a co-packing partnership with Alkame Holdings, Inc. (OTC US: ALKM).  Earlier this week, PURA published a multimedia presentation on the new initiative in Texas:

PURA Targets Hemp Consumer Advocates To Capture $26 Billion Market

 

 

Sign up to receive the latest updates at www.purationinc.com.

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.